Search

Search Results

• 

  Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients

  S. Canestri, M.C. Totaro, E. Serone, B. Tolusso, D. Frezza, E. Gremese, G. Ferraccioli

  368-373

  20-12-2012

  Published: 20 December 2012

  1971

  PDF: 754
• 

  Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient

  C. Bruni, S. Bellando-Randone, L. Gargani, E. Picano, A. Pingitore, M. Matucci-Cerinic, S. Guiducci

  109-111

  09-09-2016

  Published: 9 September 2016

  1628

  PDF: 1134
• 

  Chronic widespread pain in spondyloarthritis

  F. Atzeni, L. Boccassini, M. Di Franco, A. Alciati, A. Marsico, M. Cazzola, G. Cassisi, P. Sarzi-Puttini

  28-32

  06-06-2014

  Published: 6 June 2014

  2295

  PDF: 1537
• 

  Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement

  G. Adami, L. Idolazzi, C. Benini, E. Fracassi, A. Carletto, O. Viapiana, D. Gatti, M. Rossini, A. Fassio

  08-05-2023

  Published: 8 May 2023

  1145

  PDF: 661
• 

  Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections

  A. Laria, A. Zoli, E. Gremese, G.F. Ferraccioli

  5-10

  Published:

  2204

  PDF: 1716
• 

  Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients

  F. Cacciapaglia, M.G. Anelli, D. Rizzo, E. Morelli, C. Scioscia, D. Mazzotta, F. Iannone, G. Lapadula

  97-102

  09-02-2016

  Published: 9 February 2016

  1932

  PDF: 1191

• The treatment of recurrent uveitis with TNFα inhibitors

  P.C.F. Falappone, F. Iannone, C. Scioscia, V. Grattagliano, M. Covelli, G. Lapadula

  185-189

  Published:

  1688

  PDF: 2294
• 

  Janus kinase inhibitors: between prescription authorization and reimbursability

  F.R. Spinelli, F. Conti, R. Caporali, F. Iannone, F. Cacciapaglia, on behalf of the Steering Committee of the Italian Society of Rheumatology

  19-12-2023

  Published: 19 December 2023

  1031

  PDF: 218
• 

  Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients

  M. Ferrito, G. Cincinelli, M. Manara, R. Di Taranto, E.G. Favalli, R. Caporali

  17-07-2023

  Published: 17 July 2023

  762

  PDF: 440

• PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors

  C. Garufi, S. Mancuso, F. Ceccarelli, L. Caruso, C. Alessandri, M. Di Franco, R. Priori, V. Riccieri, R. Scrivo, S. Truglia, F. Conti, F.R. Spinelli

  05-11-2024

  Published: 5 November 2024

  207

  PDF: 93
• 

  Psoriatic arthritis: treatment strategies using biologic agents

  S. D'Angelo, C. Palazzi, I. Olivieri

  113-121

  05-06-2012

  Published: 5 June 2012

  1108

  PDF: 1133
• 

  Treatment of hyperuricemia, gout and other crystalline arthritidies

  F. Lioté

  276-283

  Published:

  1068

  PDF: 996

• The holistic management of peripheral spondyloarthritis: focus on articular involvement in patients with inflammatory bowel disease

  E. Lubrano, A. Armuzzi, S. Scriffignano, C. Felice, F.M. Perrotta, V. Venerito, S. Del Vescovo, R. Ramonda, G. Cassone, F. Atzeni, R. Caporali, F. Conti, E. Gremese, F. Iannone, M. Sebastiani, E.G. Favalli

  11-11-2024

  Published: 11 November 2024

  155

  PDF: 75

• Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice

  G. La Montagna, R. Tirri, R. Vitiello, D. Malesci, R. Buono, G. Mennillo, G. Valentini

  261-267

  Published:

  1136

  PDF: 661

• Baricitinib in polymyalgia rheumatica and giant cell arteritis: report of six cases

  D. Camellino, C. Dejaco, F. Martini, R. Cosso, G. Bianchi

  28-10-2024

  Published: 28 October 2024

  277

  PDF: 96
• 

  Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study

  F.M. Perrotta, A. Delle Sedie, S. Scriffignano, P. Volpe, E. Cordisco, N. Milano, M. Gabini, E. Lubrano

  52-59

  10-04-2020

  Published: 10 April 2020

  1684

  PDF: 998
• 

  Adult-onset systemic autoinflammatory disorders: a clinical approach

  T. Borges, A. Barbosa, S. Silva

  177-188

  28-01-2020

  Published: 28 January 2020

  3821

  PDF: 2252

• Recurrent new-onset uveitis in a patient with rheumatoid arthritis during anti-TNFα treatment

  M. Di Gangi, R. Foti, R. Leonardi, C. Leonetti, P. Castellino

  169-172

  Published:

  918

  PDF: 847

• The impact of nicotine smoking on spondyloarthritis and rheumatoid arthritis

  G. El Hasbani, J. E Nassar, A.M. Elsayed Ali, I. Uthman, A. Jawad

  24-06-2024

  Published: 24 June 2024

  2683

  PDF: 1067

• Pathophysiology of osteoarthritis: perspectives

  S. Adami, O. Viapiana

  18-25

  Published:

  1843

  PDF: 1480

• Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)

  M.T. Riccardi, A. Chialà, F. Iannone, V. Grattagliano, M. Covelli, G. Lapadula

  135-139

  Published:

  1105

  PDF: 713

• Acute toxoplasmosis infection in a patient with ankylosing spondylitis treated with adalimumab: a case report

  V.F. Azevedo, C.F. Pietrovski, M. de Almeida Santos Jr

  283-285

  Published:

  1202

  PDF: 1210

• Early rheumatoid arthritis

  F. Atzeni, P. Sarzi-Puttini

  100-117

  Published:

  1390

  PDF: 2039

• A short history of anti-rheumatic therapy. III. Non steroidal anti-inflammatory drugs

  G. Pasero, P. Marson

  225-232

  Published:

  1561

  PDF: 1142

• Septic arthritis: a 12 years retrospective study in a rheumatological university clinic

  M. Favero, F. Schiavon, L. Riato, V. Carraro, L. Punzi

  260-267

  Published:

  1518

  PDF: 1133

• Differences in pharmacology of tumor necrosis factor (TNF) antagonists

  U. Fiocco, S. Bombardieri

  8-16

  Published:

  1084

  PDF: 1724
• 

  Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy

  M. Tasso, N. Bertolini, E. Mostacciuolo, S. Passavanti, J.M.E. Luppino, A. Del Puente, R. Peluso, F. Santelli, R. Scarpa, L. Costa, F. Caso

  29-12-2022

  Published: 29 December 2022

  1598

  PDF: 709

• Pharmacological treatment of fibromyalgia

  M. Cazzola, P. Sarzi-Puttini, D. Buskila, F. Atzeni

  280-291

  Published:

  2618

  PDF: 3697

• Pain patterns in italian patients with osteoarthritis: preliminary results of the MI.D.A. Study (Misurazione del Dolore nell’Artrosi)

  M.A. Cimmino, F. Salaffi, I. Olivieri, F. Trotta, P. Sarzi Puttini, W. Grassi, V. Modena, F.P. Cantatore, S. Bombardieri, S. Adami, L. Punzi, G. Lapadula, Gruppo MI.D.A.

  253-261

  Published:

  2247

  PDF: 6208

• Therapy of rheumatic polymyalgia: the pathophysiologic management

  M. Cutolo, M. Olivieri, M.E. Secchi, M.A. Cimino

  271-279

  Published:

  1401

  PDF: 1992

• Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review

  C. Perricone, R. Dal Pozzolo, G. Cafaro, S. Calvacchi, L. Bruno, F. Tromby, A. Colangelo, R. Gerli, E. Bartoloni

  25-10-2024

  Published: 25 October 2024

  284

  PDF: 105